Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.
OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the ...
Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.
Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.
Alira Health today announced it has been awarded a Silver rating by EcoVadis, a globally recognized provider of business ...
The UK pharmaceutical market is estimated at nearly £1 billion within this category, and this agreement positions Tilray and ...
Airia, the all-in-one enterprise AI platform for orchestration, security, and governance, today announced full support for ...
Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.
SIKA TO ACQUIRE AKKIM: MARKING A MAJOR STEP IN ACCELERATING GLOBAL EXPANSION IN ADHESIVES AND SEALANTS ...
ClinicalTrials.gov. NCT04573478. A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients with IgA Nephropathy at Risk of Progressive Loss of Renal Function. Available ...
CONTROL Resonant will be published by Remedy Entertainment. Annapurna Pictures are co-financing and co-producing the game as part of a strategic partnership with Remedy Entertainment. CONTROL Resonant ...
Alkane Resources (ASX:ALK; TSX:ALK; OTCQX:ALKRY) is an Australia-based gold and antimony producer with a portfolio of three operating mines across Australia and Sweden. The Company has a strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results